Walmart will pay up to $100 million to settle a complaint by the Federal Trade Commission (FTC) and 11 states alleging the company withheld tips and misrepresented wages to drivers who deliver orders ...
The Federal Trade Commission’s (FTC's) antitrust rule requiring parties to submit additional information to regulators ahead of a planned merger was tossed by a Federal judge Thursday. The agency’s ...
Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Federal Trade Commission is ...
The US Federal Trade Commission (FTC) on Friday issued warning letters to 42 law firms, stating that their participation in a diversity certification program may violate federal antitrust laws.
The U.S. Federal Trade Commission has finalized an order with General Motors (GM) and its subsidiary, OnStar, settling charges that they collected and sold the location and driving data of millions of ...
Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...
Learn how to use advanced techniques like short-circuiting, parallel execution, virtual threads, and stream gatherers to maximize Java stream performance. My recent Java Stream API tutorial introduced ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
The Federal Trade Commission (FTC) has begun outlining its case against Edwards Lifesciences' proposed purchase of heart implant developer JenaValve after the antitrust agency announced it would move ...
As Novo Nordisk and Pfizer vie for control of Metsera, a new round of takeout proposals has resulted in the obesity biotech declaring Novo's offer "superior"—even though it has already inked an ...